Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Área temáticas
Fisiología humana(2)
Enfermedades(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Medicina y salud(1)
Salud y seguridad personal(1)
Origen
scopus(3)
Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study
ArticleAbstract: Objective: To determine the extent to which the effects of intensive blood pressure (BP) lowering arPalabras claves:acute ischemic stroke, Blood pressure lowering, Hypertension, Intracerebral Hemorrhage, thrombolysisAutores:Arima H., Chalmers J., Delcourt C., Kim J.S., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Martins S.O., Minhas J.S., Moullaali T.J., Octavio Marques Pontes-Neto, Olavarria V.V., Robinson T.G., S Anderson C., Sandset E.C., Sharma V.K., Song L., Sun L., Thang N.H., Wang J.G., Wang X., Yang J.Fuentes:scopusTriple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress
ArticleAbstract: Background: Patients who suffer intracerebral hemorrhage (ICH) are at very high risk of recurrent ICPalabras claves:Blood pressure lowering, Clinical trial, Hypertension, Intracerebral Hemorrhage, OutcomesAutores:Anderson C.S., Arima H., Billot L., Chalmers J., Chen C., Chow C.K., De Silva H.A., Fisher U., Freed R., Kherkheulidze T., Klijn C.J.M., Lee T.H., Lindley R.I., MacMahon S., Martins S.O., Naismith S., Octavio Marques Pontes-Neto, Robinson T.G., Rodgers A., Salman R.A.S., Schreuder F.H., Senanayake B., Song L., Thang N.H., Wahab K.W., Wang J.G., Woodward M., Zaidi W.A.W.Fuentes:scopusRationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment
ArticleAbstract: Rationale: Controversy exists over the optimal dose of intravenous (iv) recombinant tissue plasminogPalabras claves:Acute ischaemic stroke, Alteplase, Dose, Hypertension, Rt-PA, thrombolysisAutores:Arima H., Bath P.M.W., Broderick J.P., Chalmers J., Chen X., Demchuk A.M., Donnan G.A., Fuentes S., Huang Y., Kim J.S., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Silva-Sieger F.A., Stapf C., Wang J.G., Woodward M.Fuentes:scopus